Replies to post #101107 on Amarin Corp Plc (AMRN)

[HDGabor]

j-

Immediately means Immediately ...

a.) it was said as "could be"
b.) if it will be CF + w/o R-IT cost

Also a lot depends on if the Co/FDA feels that there are questions or data that they'd have liked to see with a full term study or a longer tracking of the Reduce It population in an open label extension of the study.

It is possible, but after more than 4 yrs on the market and after a /+ yrs long double blinded study it is not likely

But there then will be hand wringing over sales/promotion/staffing/domestic and international distribution and production ramp up expenses replacing Reduce It expenses...

This won't happen immediately ... on the next day ... I am "sure" that the Co will wait with sales / staffing / heavy promotion till FDA decides and international distribution is a revenue, isn't a cost... meanwhile sales (w/o extra resources will increase due to the fact of the stop ...

Incremental revenue will exceed the incremental cost (top of CF+ situation)

Best,
G